Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.672
-0.019 (-2.79%)
Apr 29, 2026, 10:10 AM EDT - Market open
Tenaya Therapeutics Market Cap
Tenaya Therapeutics has a market cap or net worth of $145.76 million as of April 29, 2026. Its market cap has increased by 83.06% in one year.
Market Cap
145.76M
Enterprise Value
60.23M
1-Year Change
83.06%
Ranking
Category
Stock Price
$0.67
Market Cap Chart
Since July 30, 2021, Tenaya Therapeutics's market cap has decreased from $603.63M to $145.76M, a decrease of -75.85%. That is a compound annual growth rate of -25.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 149.95M | -2.66% |
| Dec 31, 2025 | 154.04M | 35.98% |
| Dec 31, 2024 | 113.29M | -48.67% |
| Dec 29, 2023 | 220.68M | 71.58% |
| Dec 30, 2022 | 128.62M | -83.56% |
| Dec 31, 2021 | 782.28M | 29.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 159.72M |
| Tiziana Life Sciences | 159.53M |
| Alps Group | 156.07M |
| ProQR Therapeutics | 155.93M |
| Black Diamond Therapeutics | 154.68M |
| Spero Therapeutics | 154.57M |
| Galectin Therapeutics | 152.72M |
| Fate Therapeutics | 151.14M |